G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,332,084 | -13.3% | 2,543,006 | -6.6% | 0.00% | 0.0% |
| Q1 2023 | $7,300,057 | +47753.5% | 2,723,902 | -3.0% | 0.00% | -60.0% |
| Q4 2022 | $15,255 | -100.0% | 2,809,444 | -4.3% | 0.01% | -63.0% |
| Q3 2022 | $36,662,000 | +221.5% | 2,935,332 | +27.2% | 0.03% | +237.5% |
| Q2 2022 | $11,404,000 | -35.1% | 2,308,555 | -0.1% | 0.01% | -20.0% |
| Q1 2022 | $17,565,000 | -24.1% | 2,311,138 | +1.9% | 0.01% | -23.1% |
| Q4 2021 | $23,157,000 | -0.7% | 2,268,074 | +30.5% | 0.01% | -7.1% |
| Q3 2021 | $23,327,000 | +16.2% | 1,738,211 | +90.0% | 0.01% | +7.7% |
| Q2 2021 | $20,072,000 | – | 914,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |